ArticleFrontiers in pharmacology2019
Arsenic Species in
Article in Frontiers in pharmacology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed, 24 citations in OpenAlex.
- Post-marketing surveillance of cordyceps products online: identifying falsified products and regulatory challenges.BMC complementary medicine and therapies · 2026Article
- Innovative perspective on the geographical origin and quality ofJournal of pharmaceutical analysis · 2026Article
- Cordyceps sinensis and Sonodynamic Therapy in Non-Small Cell Lung Cancer: Pharmacological Basis, Therapeutic Potential, and Future Directions.International journal of nanomedicine · 2026Review
- Biological exposure and health risks of arsenic species from medicinal leeches at major exposure points in humans.Journal of pharmaceutical analysis · 2025Article
- Rapid discrimination between wild and cultivatedCurrent research in food science · 2024Article
- Unique Bioactives from Zombie Fungus (Nutrients · 2023Review
- Systematic analyses with genomic and metabolomic insights reveal a new species,Frontiers in microbiology · 2023Article
- Arsenic(III)-induced oxidative defense and speciation changes in a wild Trametes versicolor strain.PloS one · 2023Article
- Mechanism of Cordyceps sinensis and its Extracts in the Treatment of Diabetic Kidney Disease: A Review.Frontiers in pharmacology · 2022Review
- Medicinal Earthworm: Speciation and Bioaccessibility of Arsenic and Its Potential Health Risks.Frontiers in pharmacology · 2022Article
- Arsenic Content, Speciation, and Distribution in WildEvidence-based complementary and alternative medicine : eCAM · 2021Article
- Network Pharmacology-Based Strategy for Elucidating the Molecular Basis Forthe Pharmacologic Effects of Licorice (Frontiers in pharmacology · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 3 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
High arsenic residues make
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.